Filing Details
- Accession Number:
- 0001209191-17-019223
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-08 16:06:33
- Reporting Period:
- 2017-03-06
- Filing Date:
- 2017-03-08
- Accepted Time:
- 2017-03-08 16:06:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1000228 | Henry Schein Inc | HSIC | Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047) | 113136595 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1194347 | P James Breslawski | C/O Henry Schein, Inc. 135 Duryea Road Melville NY 11747 | Pres., Hsi & Ceo Global Dental | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.01 Per Share | Acquisiton | 2017-03-06 | 9,362 | $0.00 | 113,486 | No | 4 | A | Direct | |
| Common Stock, Par Value $0.01 Per Share | Disposition | 2017-03-06 | 8,486 | $170.35 | 105,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Grant of restricted stock units (RSUs) pursuant to the Issuer's 2013 Stock Incentive Plan. Subject to certain exceptions, 65% will vest subject to (x) Issuer's achievement of a specified perf. goal and (y) reporting person's continued performance of services for the Issuer. 35% will vest subject to (x) passage of a specified period of time and (y) reporting person's continued performance of services for the Issuer. With respect to the perf.-based RSUs, if the continued service requirement is satisfied and achievement of the perf. goal (x) exceeds 100% of target, the Issuer may issue additional vested shares of common stock in an amount that corresponds to the incremental percentage of the perf. goal achieved in excess of 100% of target or (y) is less than 100% of target, the reporting person will surrender to the Issuer shares of common stock in an amount that corresponds to the incremental percentage of the perf. goal achieved that is below 100% of target (i.e., shortfall).
- The price reflects a weighted average of sales made at prices ranging from $170.02 to $170.70 per share. The Reporting Person, upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, will provide full information regarding the number of shares sold at each separate price for this transaction.
Billionaire Hedge Funds
